Advertisement Biolase launches Endolase Root Canal Therapy System - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Biolase launches Endolase Root Canal Therapy System

Biolase Technology has launched its new, minimally invasive Endolase RFT Root Canal Therapy System, which is said to enable endodontists and dentists to perform root canal procedures faster and more effectively than conventional treatment methods.

The Endolase RFT Root Canal Therapy System and the Waterlase MD laser system are now available through the company’s North American distributor Henry Schein Dental, the Biolase direct operations in Australia, New Zealand, Germany and Spain, and its network of international distributors.

Endolase RFT includes two newly designed, single-use laser tips, called endoTips and the procedure protocol for use with the company’s Waterlase MD YSGG laser system. The launch of Endolase RFT, which is available for immediate delivery, marks for the first time, a complete laser treatment for root canal therapy, including access, cleaning, shaping and disinfection.

Jake St Philip, CEO of Biolase, said: “We believe this new therapy for easily and effectively performing a root canal can spawn considerable interest among consumers, increase utilization of Waterlase MD among existing users, and generate sales of new laser systems worldwide.”